Skip to main content

Propofol inhibits norepinephrine release in vivo at presynaptic varicosities of locus coeruleus neurones in zebrafish larvae.

British journal of anaesthesia2025-10-17PubMed
Total: 82.5Innovation: 9Impact: 0Rigor: 0Citation: 0

Summary

Using in vivo electrophysiology, chemogenetics, and imaging in zebrafish larvae, the authors show that propofol directly suppresses norepinephrine release at presynaptic varicosities of locus coeruleus neurons. This establishes a presynaptic noradrenergic mechanism contributing to anesthetic-induced hypnosis beyond effects on excitability and synaptic input.

Key Findings

  • Propofol directly inhibits norepinephrine release at presynaptic varicosities of LC–NE neurons in vivo.
  • The study leveraged in vivo whole-cell recordings, chemogenetics, and time-lapse imaging in intact zebrafish larvae.
  • Findings establish a presynaptic noradrenergic mechanism contributing to anesthetic-induced hypnosis.

Clinical Implications

While preclinical, these findings support targeting the LC–NE axis for sedative design and may explain arousal, hemodynamic, and delirium-related effects of agents that modulate noradrenergic tone.

Why It Matters

This work reveals a previously unproven presynaptic site of action for propofol in the LC–NE system, advancing mechanistic understanding of anesthesia.

Limitations

  • Findings are in zebrafish larvae with uncertain translatability to humans
  • Incomplete mechanistic delineation in the abstract (e.g., calcium dynamics, receptor targets) and no human validation

Future Directions

Validate presynaptic noradrenergic suppression across species, quantify dose–effect relationships relevant to clinical sedation, and identify molecular mediators for targeted drug development.

Study Information

Study Type
Basic/mechanistic research
Research Domain
Pathophysiology
Evidence Level
V - Preclinical mechanistic study without clinical outcomes
Study Design
OTHER